Patrick Soon-Shiong Net Worth is
Patrick Soon-Shiong Biography
He’s now chairman of the Chan Soon Shiong Family Foundation and chairman and CEO of the Chan Soon Shiong Institute for Complex Health, National LambdaRail, the Healthcare Transformation Institute and NantWorks, LLC. He’s minority owner of the Los Angeles Lakers and is rated by Forbes as the most affluent American in the health care business as well as the richest man in LA.
In 1993, Soon Shiong performed the planet ‘s first encapsulated individual islet transplant, an experimental Type-1 diabetes treatment, as well as the primary pig to man islet cell transplant. He devised the country ‘s first FDA approved protein nanoparticle delivery technology for treating metastatic breast cancer, doubling the reaction rate in patients. He received support in the National Institutes of Health, as well as the NASA Space Shuttle program. The drug Abraxane is now approved in over 40 states, and currently in trials for lung, melanoma, gastric, and pancreatic cancer. APP was responsible for the merely safe way to obtain Heparin in America in 2008, when supplies from some other sources were found to be tainted. Soon Shiong was to the faculty of UCLA Medical School from 1983 to 1991. He briefly left UCLA in 1991 to take up a diabetes and cancer biotechnology company that eventually became American Pharmaceutical Partners and Abraxis BioScience. Soon Shiong founded American Pharmaceutical Partners (APP) in 1997. He sold the business to Fresenius SE for $5.6 billion in July 2008.
Patrick Soon-Shiong Net Worth $7.3 Billion Dollars
|Full Name||Patrick Soon-Shiong|
|Net Worth||$9 Billion|
|Date Of Birth||July 29, 1952|
|Place Of Birth||Port Elizabeth, South Africa|
|Education||University of the Witwatersrand, University of California, Los Angeles, University of British Columbia|
|Nationality||United States of America|
|60 Minutes||2014||TV Series documentary||Himself - Doctor & Entrepreneur (segment "Disrupting Cancer")|
|Larry King Now||2014||TV Series||Himself - Guest|